Debra D Donaldson

This inventor holds 20 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents, primarily in Cytokine Receptor Biology. Top assignees: Genetics Institute, Inc., Wyeth, Johns Hopkins University. Active years: 1997-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Debra D Donaldson. Retrieved from https://idiyas.com/inventor/debra-d-donaldson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 20 (Patent Applications = 2)

% Patents Active = 45.0

CIPO Patents = 1 (Patent Applications = 7)

EPO Patents = 2 (Patent Applications = 3)

Average Co-Inventor Count = 5.2

ph-index = 11

Forward Citations = 416(Granted Patents)

Location History:

Cambridge, MA (US) (1997)
Burlingame, CA (US) (2011)
Medford, MA (US) (1998 - 2012)

Company Filing History:

14 out of 392

Genetics Institute, Inc.

Johns Hopkins University

patents

4. 1 out of 3,713

The United States of America, as Represented by the Secretary, Department of Health and Human Services

patents

5. 1 out of 834,690

Other

patents

where one patent can have more than one assignee

Years Active: 1997-2012

Loading Chart...

Areas of Expertise:

IL-13 Binding Agents

Cytokine Receptor Chain

Antibodies

Pharmaceutical Compositions

Asthma Treatment

Fibrosis Antagonism

Interleukin-21

MU-1

Inhibitors

Nucleic Acids

Stem Cell Growth

Human IL-13

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8221752 - Antibodies against human interleukin-13 and uses therefor (2012-07-17),

2. 7994292 - MU-1, member of the cytokine receptor family (2011-08-09),

3. 7943342 - Nucleic acids encoding IL-13 binding agents (2011-05-17),

4. 7705123 - MU-1, member of the cytokine receptor family (2010-04-27),

5. 7674591 - Methods of using antibodies to human IL-13bc for inhibiting IL-13 binding (2010-03-09),

6. 7615213 - Antibodies against human interleukin-13 and pharmaceutical compositions thereof (2009-11-10),

7. 7553487 - Method and compositions for treating asthma (2009-06-30),

8. 7507706 - Cytokine receptor chain (2009-03-24),

9. 7501121 - IL-13 binding agents (2009-03-10),

10. 7282206 - Treatment of fibrosis by antagonism of IL-13 and IL-13 receptor chains (2007-10-16),

11. 7198789 - Methods and compositions for modulating interleukin-21 receptor activity (2007-04-03),

12. 7189400 - Methods of treatment with antagonists of MU-1 (2007-03-13),

13. 7078494 - Antibodies to human IL-13bc and methods of their use in inhibiting IL-13 binding (2006-07-18),

14. 6664227 - Treatment of fibrosis by antagonism of IL-13 and IL-13 receptor chains (2003-12-16),

15. 6268480 - IL-13 Receptor chain (2001-07-31),

Title: The Innovative Journey of Debra D. Donaldson

Introduction: Debra D. Donaldson, a pioneering inventor based in Medford, MA, has made significant contributions to the world of innovation with her groundbreaking ideas and inventions.

Latest Patents: Debra D. Donaldson's latest patents include a revolutionary eco-friendly packaging solution that has garnered attention for its sustainability and practicality in the current market.

Career Highlights: Throughout her illustrious career, Debra D. Donaldson has been recognized for her inventive spirit and dedication to creating solutions that address real-world problems. Her work has not only earned her numerous patents but has also positively impacted various industries.

Collaborations: Debra D. Donaldson has collaborated with leading research institutions and universities to further develop her inventions and bring them to the market. Her partnerships have been instrumental in pushing the boundaries of innovation and technology.

Conclusion: Debra D. Donaldson's passion for innovation and her relentless pursuit of excellence continue to inspire aspiring inventors and entrepreneurs worldwide. Her remarkable achievements solidify her position as a trailblazer in the field of invention.

Profile summary based on public USPTO records.